Patents by Inventor Wade RICHARDSON

Wade RICHARDSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220347213
    Abstract: T cells are transfected with a recombinant RNA molecule that encodes at least one of an alpha chain and a beta chain of a CD1b restricted T cell receptor. Preferably, the so prepared T cells are used as a cell-based therapeutic composition to treat tuberculosis.
    Type: Application
    Filed: August 6, 2019
    Publication date: November 3, 2022
    Inventors: Wade Richardson, Ting Wu, Peter Sieling, Kayvan Niazi
  • Publication number: 20220047862
    Abstract: Systems and methods are provided for transfecting cells, such as mammalian cells and nonmammalian cells, using an electroporation apparatus having an electroporation chamber including a first electrode, a second electrode and a path defined in the electroporation chamber. The electroporation apparatus includes a first input allowing passage of cells and cargo into the electroporation chamber and a first output allowing passage of electroporated cells from the electroporation chamber.
    Type: Application
    Filed: October 28, 2021
    Publication date: February 17, 2022
    Inventors: Chihwei CHANG, Wade RICHARDSON, Artin MEHRABI
  • Patent number: D1016324
    Type: Grant
    Filed: October 20, 2021
    Date of Patent: February 27, 2024
    Assignee: NanoCav, LLC
    Inventors: Chihwei Chang, Wade Richardson, Artin Mehrabi